investorrelations.adacap.com

Investor Home | Investor Relations | Advanced Accelerator Applications – AAA

01/11/17 4:00 pm ET. Advanced Accelerator Applications (AAA) is an innovative radiopharmaceutical company that develops, produces and commercializes molecular nuclear medicine, or MNM, products. AAA is a European leader in the production and commercialization of molecular nuclear diagnostic radiopharmaceuticals for PET and SPECT. These radiopharmaceuticals are mainly used for diagnosis in clinical oncology, cardiology and neurology. January 11, 2017. Click here for Webcast. Stock Quote and Chart.

http://investorrelations.adacap.com/

OVERVIEW OF investorrelations.adacap.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

0

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR INVESTORRELATIONS.ADACAP.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

October

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Wednesday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 3.7 out of 5 with 14 reviews

5 star

3

4 star

6

3 star

4

2 star

0

1 star

1

Hey there! Start your review of investorrelations.adacap.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

0.7 seconds

CONTACTS AT INVESTORRELATIONS.ADACAP.COM

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

PAGES IN
THIS WEBSITE

0

SSL

EXTERNAL LINKS

40

SITE IP

184.25.56.204

LOAD TIME

0.734 sec

SCORE

6.2

PAGE TITLE

Investor Home | Investor Relations | Advanced Accelerator Applications – AAA | investorrelations.adacap.com Reviews

<META> DESCRIPTION

01/11/17 4:00 pm ET. Advanced Accelerator Applications (AAA) is an innovative radiopharmaceutical company that develops, produces and commercializes molecular nuclear medicine, or MNM, products. AAA is a European leader in the production and commercialization of molecular nuclear diagnostic radiopharmaceuticals for PET and SPECT. These radiopharmaceuticals are mainly used for diagnosis in clinical oncology, cardiology and neurology. January 11, 2017. Click here for Webcast. Stock Quote and Chart.

<META> KEYWORDS

1 advanced accelerator applications

2 about us

3 our purpose

4 history

5 our business

6 manufacturing expertise

7 our sites

8 board of directors

9 corporate executive team

10 corporate social responsibility

CONTENT

Page content here

KEYWORDS ON PAGE

advanced accelerator applications,about us,our purpose,history,our business,manufacturing expertise,our sites,board of directors,corporate executive team,corporate social responsibility,code of conduct,careers,products home,special programs,r&d home,news

POWERED BY

ASP.NET

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Investor Home | Investor Relations | Advanced Accelerator Applications – AAA | investorrelations.adacap.com Reviews

https://investorrelations.adacap.com

01/11/17 4:00 pm ET. Advanced Accelerator Applications (AAA) is an innovative radiopharmaceutical company that develops, produces and commercializes molecular nuclear medicine, or MNM, products. AAA is a European leader in the production and commercialization of molecular nuclear diagnostic radiopharmaceuticals for PET and SPECT. These radiopharmaceuticals are mainly used for diagnosis in clinical oncology, cardiology and neurology. January 11, 2017. Click here for Webcast. Stock Quote and Chart.

LINKS TO THIS WEBSITE

adacap.com

Board of Directors | Advanced Accelerator Applications – AAA

http://www.adacap.com/company/board-of-directors

Bridging science with life. Research & Development. News & Events. Conferences & Events.

adacap.com

Our Sites | Advanced Accelerator Applications – AAA

http://www.adacap.com/company/aaa-sites

Bridging science with life. Research & Development. News & Events. Conferences & Events. AAA operates in Belgium, Canada, France, Germany, Israel, Italy, the Netherlands, Poland, Portugal, Spain, Switzerland, UK and U.S. while its distribution network covers more than 30 countries. Please point to any of the locations to pull up specific details about each facility. Advanced Accelerator Applications Ibérica S.L. Hospital Universitario Virgen de La Arrixaca. Carretera Madrid Cartagena S/N. F-18 radiopharm...

adacap.com

Press Room | Advanced Accelerator Applications – AAA

http://www.adacap.com/press-room

Bridging science with life. Research & Development. News & Events. Conferences & Events. August 3, 2016. Advanced Accelerator Applications Announces First Administration of NETSPOT at Holy Name Medical Center. Stefano Buono, Chief Executive Officer of AAA said,. We are proud to contribute to the introduction of pharmaceutical products that improve patient care, while decreasing healthcare costs. August 2, 2016. Advanced Accelerator Applications Announces Clinical Trial Agreement with National Cancer Inst...

adacap.com

News | Advanced Accelerator Applications – AAA

http://www.adacap.com/category/news

Bridging science with life. Research & Development. News & Events. Conferences & Events. August 3, 2016. Advanced Accelerator Applications Announces First Administration of NETSPOT at Holy Name Medical Center. Stefano Buono, Chief Executive Officer of AAA said,. We are proud to contribute to the introduction of pharmaceutical products that improve patient care, while decreasing healthcare costs. August 2, 2016. Advanced Accelerator Applications Announces Clinical Trial Agreement with National Cancer Inst...

adacap.com

About Us | Advanced Accelerator Applications – AAA

http://www.adacap.com/company

Bridging science with life. Research & Development. News & Events. Conferences & Events. Advanced Accelerator Applications (AAA) is an innovative radiopharmaceutical company that develops, produces and commercializes molecular nuclear medicine, or MNM, products. AAA is a European leader in the production and commercialization of molecular nuclear diagnostic radiopharmaceuticals for PET and SPECT. These radiopharmaceuticals are mainly used for diagnosis in clinical oncology, cardiology and neurology.

adacap.com

Our Business | Advanced Accelerator Applications – AAA

http://www.adacap.com/company/our-business

Bridging science with life. Research & Development. News & Events. Conferences & Events. AAA is the fastest-growing player in the European radiopharmaceutical PET market. At AAA we have:. A unique industrial approach to PET production: largest EU presence of industrial proprietary laboratories. A reliable pharmaceutical production in PET. A best-in-class technology and highest pharmaceutical standards. Production and R&D activities in tandem to drive innovation. A proven track record. Our key therapy pro...

adacap.com

Products | Advanced Accelerator Applications – AAA

http://www.adacap.com/products

Bridging science with life. Research & Development. News & Events. Conferences & Events. Advanced Accelerator Applications (AAA) develops, produces and commercializes diagnostic and therapeutic Molecular Nuclear Medicine products in the fields of oncology, neurology, cardiology and infectious and inflammatory diseases. AAA has built a leadership position in Molecular Nuclear Medicine in Europe by manufacturing and commercializing a portfolio of seven diagnostic PET. PET imaging of somatostatin receptor o...

adacap.com

Support Services | Advanced Accelerator Applications – AAA

http://www.adacap.com/products/support-services

Bridging science with life. Research & Development. News & Events. Conferences & Events. An App to order radiopharmaceuticals and follow their shipments in real time. AAA has developed an internet application that enables clients to order radiopharmaceuticals with AAA and follow their shipments in real time. This App is called AAA-MNM. It works on iPhone, iPad, iPod Touch and can also be accessed online via the internet. With AAA-MNM our clients can:. Access our press room.

adacap.com

History | Advanced Accelerator Applications – AAA

http://www.adacap.com/company/history

Bridging science with life. Research & Development. News & Events. Conferences & Events. Advanced Accelerator Applications (AAA) is created as a spin-off of the CERN. Construction of AAA’s first radiopharmaceutical laboratory in the Technoparc of Saint-Genis-Pouilly (Rhône-Alpes, France). First Marketing Authorization from the Swiss Authorities to commercialize GLUSCAN in Switzerland. AAA completes the construction of its second radiopharmaceutical production plant in Venafro (Molise, Italy). Initial equ...

adacap.com

Our Purpose | Advanced Accelerator Applications – AAA

http://www.adacap.com/company/mission-strategy

Bridging science with life. Research & Development. News & Events. Conferences & Events. Advanced Accelerator Applications (AAA) aims at bridging the traditional gap between scientific findings and their practical use as life enhancing applications, with a major focus on the rapidly growing new Molecular Medicine academic research.

UPGRADE TO PREMIUM TO VIEW 30 MORE

TOTAL LINKS TO THIS WEBSITE

40

SOCIAL ENGAGEMENT

adacap_news

OTHER SITES

investorrehabdeals.com

www.investorrehabdeals.com

investorrehabfunding.com

Investor Rehab Funding | The future of hard money lending . . . Today!

Welcome to Investor Rehab Funding! Finance Up To 90% Of Purchase Price! Plus 100% Rehab Cost - 500 FICO Scores Accepted! GET PREQUALIFIED NOW- NO CREDIT PULL REQUIRED. NEW 3 and 8 YR Fixed Rate. Investor Purchase and Refi. 500 FICO Scores Accepted! Investor Purchase Or Refinance). 6 or 12 Month Financing Terms! NEW 3 and 8 YR Fixed Rate. Investor Purchase and Refi. As Low As 8% Interest! Based On LTV And Experience). Fixed Interest Only Monthly Payments! NEW 3 and 8 YR Fixed Rate. Do not hesitate to cont...

investorrehabs.com

Sacramento California real estate investment properties - Full Service Real Estate Investment - American River Properties, Inc.

Want To Work With Us? American River Properties, Inc. Real Estate Investment Company. Investment Properties For Sale. Free Report: Secrets Of Selling Your House in 7 Days. Investing In Real Estate With Your IRA. Free Report: How to Earn 7-10 Percent Secured By Real Estate. Access California Investment Property Deals…. Access Local California Investment Property Deals. What Kind Of Buyer Are You? Looking for a place to live in. This field is for validation purposes and should be left unchanged. Face today...

investorrelate.com

Welcome to your new website

Welcome to your new website. Domain names for less with UK2. Claim your web identity. Has been registered by a customer of UK2. Claim your web identity. With hundreds of domain name extensions to choose from, we're sure you'll find the right web address to house your website. Click here to view. The grass really is greener with UK2, which is why we’ve made it easy to transfer your website address or domain name to us from other companies. Click here to view. Click here to view. Click here to view. Find o...

investorrelation.info

investorrelation.info - This domain may be for sale!

Find the best information and most relevant links on all topics related to investorrelation.info. This domain may be for sale!

investorrelations.adacap.com

Investor Home | Investor Relations | Advanced Accelerator Applications – AAA

01/11/17 4:00 pm ET. Advanced Accelerator Applications (AAA) is an innovative radiopharmaceutical company that develops, produces and commercializes molecular nuclear medicine, or MNM, products. AAA is a European leader in the production and commercialization of molecular nuclear diagnostic radiopharmaceuticals for PET and SPECT. These radiopharmaceuticals are mainly used for diagnosis in clinical oncology, cardiology and neurology. January 11, 2017. Click here for Webcast. Stock Quote and Chart.

investorrelations.almequity.se

Aktien

DELÅRSRAPPORT JANUARI - SEPTEMBER 2015. DELÅRSRAPPORT JANUARI - MARS 2015. Pressmeddelanden, rapporter och årsredovisningar. Bli först med att få våra projektnyheter. ALM EQUITY AB (Publ). JAKOBSBERGSGATAN 22, 111 44 STOCKHOLM. 46) 08-550 029 68. ATT KÖPA BOSTAD.

investorrelations.avx.com

Official Investor News from AVX Corporation |

Proxy Info and Materials. AVX is a leading worldwide manufacturer and supplier of a broad line of passive electronic components and Interconnects. 1/6/17 9:00 am EST. AVX Corporation Schedules Third Quarter Earnings Conference Call. 10/26/16 8:30 am EDT. AVX Corporation Announces Preliminary Second Quarter Results. 10/20/16 9:00 am EDT. AVX Corporation Declares Increased Dividend. 10/7/16 9:29 am EDT. AVX Corporation Schedules Second Quarter Earnings Conference Call. Q2 FY2017 Financial Statements.

investorrelations.bankofireland.com

Investor Relations – Bank of Ireland

Bank of Ireland Overview. Bank of Ireland Overview. Bank of Ireland Subsidaries. Announcements and Press Releases. Prospectus: Final Terms and Related Documents. Q3 2016 Interim Management Statement. Bank of Ireland has released its Q3 2016 Interim Management Statement. Bank of Ireland has released its Interim Results for the first half of 2016. Last updated at 09:33 12/01/2017. Bank of Ireland has released its Interim Results for the first half of 2016. Interim Management Statement October 2016 - 197 KB.

investorrelations.bebe.com

bebe |

SIGN IN / CREATE. Looks We ❤. Looks We ❤. DragByHandle":true,"cssSelector":"ql-thumbnail","dragByBody":false,"widgetClass":"OverlayWidget","bindings":{"bind0":{"element":".ql-thumbnail .Quicklook .trigger","type":"quicklookselected","fn":"function(){$.fnProxy(arguments, '#headerOverlay ',OverlayWidget.show, 'OverlayWidget.show ');}"} ,"effectOnHide":"clip","effectOnShowOptions":"{ "mode ": "show ", "direction ": "horizontal "}","closeOnBackgroundClick":true,"effectOnHideOptions":"...8/12/15 2:00 pm PDT.

investorrelations.betssonab.com

Betsson AB - Investor relations

Under denna flik finner du som investerare nödvändig information som är kopplat till Betssons aktie. Du kan till exempel hitta Betsson AB:s finansiella rapporter och presentationer, både aktuella och historiska. I sidomenyn till vänster hittar du mer information. Anmäl dig till email registrering. Kvartal 3, 2015, presenteras den 22 oktober 2015 kl. 10.00 (CET). Delårsrapporten kommer att offentliggöras kl. 07.30 (CET) samma datum. 15490 SEK -0.90 SEK. Senast uppdaterad: 2015-08-14 17:29.